<乌鸦传媒>Health Officer May Get $4M to Step Down But outcome of months-long saga between county officials and health officer remains uncertain Nov 15, 2023
<乌鸦传媒>PPAR Agonist Led to 'Clinically Meaningful' Improvement in PBC-Related Pruritus Seladelpar also improved markers of disease activity versus placebo Nov 15, 2023
<乌鸦传媒>'We're Not There Yet': CAR T-Cell Therapy for Renal Cell Carcinoma Potential standard of care after current therapies, but key obstacles remain in the way Nov 15, 2023
<乌鸦传媒>Novel MASH Drug Reduces Liver Fat in Mid-Stage Trial At highest dose, thyroid hormone receptor-beta agonist decreased liver fat content by 45% Nov 15, 2023
<乌鸦传媒>Clinical Challenges: Managing Toxicities of Newer Breast Cancer Therapies Antibody-drug conjugates in particular may present clinicians with less familiar side effects Nov 15, 2023
<乌鸦传媒>FDA OKs Product to Thwart Bloodstream Infections During Dialysis Taurolidine-heparin solution reduced infections by 71% versus heparin alone Nov 15, 2023
<乌鸦传媒>Suicide Rates High in Older Men; Novel Ketamine Pill; SSRIs' Sexual Side Effects News and commentary from the psychiatry world Nov 15, 2023
<乌鸦传媒>Invasive Mental Health Questions Have No Place on Nurse Licensing Applications Removing these inquiries will protect nurse well-being Nov 15, 2023
<乌鸦传媒>Clinical Challenges: Test Your Knowledge on Atopic Dermatitis A three-question quiz on JAK inhibitors, differential diagnoses, and managing AD in infants Nov 15, 2023
<乌鸦传媒>Clinical Challenges: Atopic Dermatitis in Infants Studies show that early disease control lowers risk of developing other atopic morbidities Nov 15, 2023
<乌鸦传媒>Added Leukotriene Receptor Antagonists Show Benefits in Chronic Urticaria Off-label use along with antihistamines improved activity, itch, and wheal count scores Nov 15, 2023
<乌鸦传媒>Study Outlines the Considerable Costs of Keratoconus Cumulative economic burden totals $3.8 billion Nov 15, 2023
<乌鸦传媒>Alleged Stroke Trial Misconduct; Ultrasound Tx for Severe AS; Farxiga's eGFR Drops Recent developments of interest in cardiovascular medicine Nov 15, 2023
<乌鸦传媒>COVID Aid Grifters Waste Billions; Inside Cohen's CDC; Forged Neuro Data? This past week in healthcare investigations Nov 15, 2023
<乌鸦传媒>CAR T-Cell Approach to Autoimmune Disease Gains Traction Worries about vaccine responsiveness relieved; Big Pharma gets interested Nov 15, 2023
<乌鸦传媒>COVID Rebound May Occur in 20% of Paxlovid Users New data could also give insight on how to manage it Nov 15, 2023 video
<乌鸦传媒>AMA Delegates Spar Over Requirements for On-Site Emergency Physicians in Every ED Some want model scope-of-practice legislation, but access concerns persist Nov 15, 2023
<乌鸦传媒>Clinical Challenges: Approaches to Managing Steatotic Liver Disease Screening and timely lifestyle modification are key, using a multidisciplinary approach Nov 15, 2023
<乌鸦传媒>Uh-Oh, Is a Robot Coming for Your Radiographic Analysis Job? Computer matches live expert in measuring joint space and erosions Nov 15, 2023
<乌鸦传媒>Anthrax Guidance Issued; FDA Warns Amazon; AI Deepfakes Challenge Public Health Health news and commentary from around the Web gathered by 乌鸦传媒 staff Nov 15, 2023
<乌鸦传媒>Tackling Climate Change Starts With a Focus on Health, Lancet Report Says Heat-related deaths, extreme weather, increased disease spread are already a problem Nov 14, 2023
<乌鸦传媒>Statins Reach More Patients With Pharmacist's Orders Asynchronous automated order approach boosts statin prescribing Nov 14, 2023
<乌鸦传媒>AMA Delegates Take Action on Cannabis, Medical Aid-in-Dying Resolutions Concern expressed about lack of available evidence on harms of marijuana Nov 14, 2023
<乌鸦传媒>IG Live November 15: Is 'Pharmageddon' Here? Pharmacist speaks on recent walkouts, calling for more resources and safer conditions Nov 14, 2023
<乌鸦传媒>Addiction Societies Issue Guidance on Stimulant Use Disorder "The main takeaway is that stimulant use disorder is treatable," society president says Nov 14, 2023
<乌鸦传媒>Targeting New Pathways to Improve Outcomes in Renal Cell Carcinoma Building on recent success requires intervention at multiple steps in the cancer immunity cycle Nov 14, 2023
<乌鸦传媒>Lymphoma Drug Copanlisib to Be Pulled From U.S. Market Failed confirmatory trial takes down another PI3K inhibitor Nov 14, 2023
<乌鸦传媒>Long COVID Immune Profiles Appear Largely Normal Brain inflammation may not be a cause of long COVID cognitive problems Nov 14, 2023
<乌鸦传媒>Novel BTK Inhibitor for Chronic Hives Wins in Phase III Trials Remibrutinib demonstrated superiority over placebo in both the REMIX-1 and -2 trials Nov 14, 2023
<乌鸦传媒>New Guselkumab Responses in Ulcerative Colitis Emerge After 12 Weeks More than half of patients not in early clinical response at week 12 responded by week 24 Nov 14, 2023 video
<乌鸦传媒>Emergency Liver Transplant Effective for Severe Acute-on-Chronic Liver Failure 1-year survival reached 78% for patients who received an emergency transplant Nov 14, 2023
<乌鸦传媒>Handheld Device Detects Alzheimer's Biomarkers; Long COVID Smell Loss; MS Fatigue News and commentary from the world of neurology and neuroscience Nov 14, 2023
<乌鸦传媒>Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes News and commentary from the endocrinology world Nov 14, 2023
<乌鸦传媒>Americans Struggling With Addiction, Mental Health, SAMHSA Survey Shows Biden administration highlights need for better access to treatment Nov 14, 2023
<乌鸦传媒>New Data on CD40 Ligand Inhibitor for Relapsing MS Novel agent led to sustained reduction of new lesions at 24 weeks Nov 14, 2023 video
<乌鸦传媒>We're Failing to Treat Early Psychosis Symptoms in Black Children Early intervention is the best way to avoid dire consequences Nov 14, 2023
<乌鸦传媒>Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis In randomized trial, oral elafibranor induced biochemical response at 1 year in 51% of patients Nov 14, 2023
<乌鸦传媒>More Investment in Pediatric Readiness Will Save Lives in the ED The situation has improved but more can be done Nov 14, 2023
<乌鸦传媒>Diabetes Linked to Higher Colorectal Cancer Risk Associated risks highest in those with recent diagnoses Nov 14, 2023
<乌鸦传媒>Novel IL-17A Blocker Continues to Impress in PsA More phase II data build case for izokibep Nov 14, 2023
